Pediatric hematological malignancy: Identification of issues involved in the road to diagnosis

Abstract

Introduction:Childhood malignancy, although a rare phenomenon, is still the leading cause of mortality in the pediatric population. Early diagnosis and treatment are imperative for the achievement of optimal prognosis. The study of factors facilitating the delay in diagnosis is thus of utmost importance, to both shorten the diagnostic delay and allow for early therapeutic intervention, facilitating a higher prognosis.Objective:To assess the referral pattern and the identification of potential delays in the diagnosis of childhood malignancy in a developing country.Methodology:The study was conducted in the Pediatric Hematology and Oncology department of Sri Ramachandra University, Chennai, India. The study included randomly selected 70 pediatric patients diagnosed with a hematological malignancy, from July 2012-August 2013. The parents were interviewed using a prepared questionnaire about patient symptomatology, interaction with healthcare providers, final diagnosis, and referral details. Data were statistically analyzed using Statistica® (STATsoft).Results:70 patients were included in the study (69% boys, 31% girls). The diagnostic delay was primarily due to the delay experienced in the healthcare system, with a mean delay of 26 days (Median: 18; Range: 5-39). Those from a lower socioeconomic background and whom opted for a non-allopathic treatment approach experienced higher diagnostic delays. Diagnostic time was significantly shorter for those who visited a pediatrician versus the patients who visited a general physician or super specialties (P = 0.043).Conclusions:Diagnostic delay is often associated with an extensive disease presentation, an aggressive therapeutic approach, and has a negative impact on patient prognosis. To lower mortality rate and facilitate a favourable prognosis, diagnosis requires a high degree of clinical suspicion and immediate intervention.

A Retrospective Study of Factors Affecting Pathway and Time to Diagnosis, Time to Treatment in Children with Cancer in a Single Center in South India

“…There was a statistically significant correlation between family income and time to see a doctor or TTD in our study. Similar findings were noted in Venkatasai et al 18 and Begum et al 19 However, Verma and Bhattacharya 24 did not show any correlation with economic background. Our study, like a study by Abdelkhalek et al, 17 did not reveal any correlation between the patient's places of residence, whether it was rural or urban to TTD.…”

A health care labyrinth: perspectives of caregivers on the journey to accessing timely cancer diagnosis and treatment for children in India

“…Some Indian studies have quantified the time intervals to diagnosis for various childhood cancers such as retinoblastoma, leukaemia and meningioma, where intervals ranged from 0.3 to 521 weeks [12–14]. Reasons for such delays in India included caregiver education level, geographical distances, job demands of the caregiver and multiple healthcare referrals, which were mainly investigated through questionnaires [15, 16]. These provide useful information but lack in-depth analysis about the interplay of barriers in relation to participant's feelings, attitudes and behaviours.…”

The importance of “early diagnosis” to improve the prognosis in children with cancer: a prevalent concept for 50 years with little scientific support

“…29,30 Some analyses have included the reference time from first contact clinics to oncological care centers as an involved factor. 25,31 More swiftness (< 5 days) has been observed in better integrated health systems, 27 as opposed to those with administrative deficiencies. 27,31 About TTD in Mexico, at least in lymphomas, it has been established to be 20 weeks, 24 as compared to 7.1 to 14 weeks in the United States; 22,23 in particular, for Burkitt lymphomas, TTD was less than 4.5 weeks at Centro Médico Nacional Pediatrics Hospital, 32 with 80 % of patients being at stages III-IV.…”